Skip to main content
2024 DC-CSEM Conference Main banner
On-Demand

Science

DC2412 - Exploring Cardiovascular, Renal, and Metabolic management in Diabetes Care

Thursday, November 21, 2024
11:15 - 12:30 AT Time
Location: Argyle A1-2

    Speaker(s)

  • Julie A. Lovshin, MD, PhD (she/her/hers)

    Endocrinologist & Clinical Investigator
    Sunnybrook Hospital, University of Toronto
    University of Toronto
    Toronto, Ontario, Canada

    Disclosure(s): I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose

  • Kristin K. Clemens, MD, MSc, FRCPC (she/her/hers)

    Clinician Scientist
    Western Unversity
    Western University
    London, Ontario, Canada

    Disclosure(s): ACT Consortium/CIHR: Grant/Research Support (Ongoing); CPD Network: Speaker/Honoraria (Ongoing); Diabetes Canada: Grant/Research Support (Ongoing); Western University: Grant/Research Support (Ongoing)

  • Abhinav Sharma, MD, PhD

    Assistant Professor
    Division of Cardiology, McGill University
    McGill University
    Montreal, Quebec, Canada

    Disclosure(s): I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose

    • Moderator(s)

  • SB

    SONIA BUTALIA, MD, FRCPC, MSc (she/her/hers)

    Associate Professor of Medicine and Community Health Sciences
    University of Calgary
    University of Calgary
    Calgary, Alberta, Canada

    Disclosure(s): Canadian Institutes of Health Research (CIHR): Grant/Research Support (Ongoing); Diabetes Canada: Grant/Research Support (Ongoing); JDRF: Grant/Research Support (Ongoing)

Learning Objectives:

  • Comprehend the Interrelationship between Cardiovascular, Kidney, and Metabolic Health in Diabetes: o Identify the shared risk factors and common pathways linking these complications in people living with diabetes o Explore the pathophysiological mechanisms underlying these interconnected complications.
  • Assess Current and Emerging Strategies for Cardiovascular and Kidney Protection in Diabetes: o Evaluate the effectiveness of current pharmacological and non-pharmacological interventions aimed at reducing cardiovascular and kidney complications. o Discuss the potential of new therapeutic approaches and their integration into clinical practice.
  • Implement Comprehensive Management Plans for Optimal Metabolic Control in Diabetes: o Analyze case studies and clinical trial data to understand the impact of integrated management approaches on patient outcomes.